| The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer (NCT01023802) | Mayo Clinic | 2009-02-01 |
| Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years (NCT05604950) | Yongtao Han | 2009-01-01 |
| Gemcitabine,Vincristine and Cisplatin as Second Line Combination Therapy in Patients With Sarcoma (NCT01192633) | Fudan University | 2009-01-01 |
| Safety and Feasibility of Fasting While Receiving Chemotherapy (NCT00757094) | King Fahad Medical City | 2008-09-01 |
| Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic Drugs (NCT01208545) | NeuroMetrix, Inc. | 2008-07-01 |
| Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C (NCT00671996) | Egetis Therapeutics | 2008-06-01 |
| Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm (NCT00776724) | National Taiwan University Hospital | 2008-05-29 |
| Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer (NCT00888810) | Centre Francois Baclesse | 2008-03-01 |
| Various G-CSF Regimens to Prevent Infection During Chemotherapy (NCT00536081) | Academisch Ziekenhuis Maastricht | 2008-01-01 |
| A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy (NCT00555516) | Tri-Service General Hospital (TSGH) | 2007-11-01 |
| Orally Fludarabine, Adriamycin and Dexamethasone (FAD) in Newly Diagnosed Peripheral T-cell Lymphomas (PTCL) (NCT00840385) | Fudan University | 2007-11-01 |
| DNA Repair Genes and Outcomes in Patients With Stage III NSCLC (NCT00797238) | National Taiwan University Hospital | 2007-09-01 |
| Garlic in Patients With Febrile Neutropenia (NCT00247039) | Hadassah Medical Organization | 2006-06-01 |
| Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting (NCT00503386) | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | 2006-04-01 |
| Tolerance and Pharmacokinetics With Capecitabine 5 Out of 7 Days Regimen (NCT00324610) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2006-03-01 |
| The Activity Intervention for Chemobrain (NCT00495703) | Vanderbilt University Medical Center | 2006-02-01 |
| Drug Delivery and Toxicities of Adjuvant Chemotherapy in Resected NCSLC (NCT00484016) | Washington University School of Medicine | 2006-02-01 |
| Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer (NCT00178373) | University of Rochester | 2004-05-01 |
| Intensified Chemotherapy in CRC After Resection of Liver Metastases (NCT00208260) | Institut du Cancer de Montpellier - Val d'Aurelle | 2004-04-01 |
| Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia (NCT00338299) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-08-01 |
| Ginger Control of Chemotherapy Induced Nausea and Vomiting (NCT00065221) | National Center for Complementary and Integrative Health (NCCIH) | 2003-06-01 |
| Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer (NCT00525642) | Fudan University | 2003-06-01 |
| A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. (NCT00341055) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-06-01 |
| An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Week or Every Four Weeks (NCT00337948) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2003-02-01 |
| Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia (NCT00315484) | Ortho Biotech Products, L.P. | 2003-02-01 |
| RAPID-2. A Study to Evaluate the Effectiveness of Alternate Dosing of PROCRIT (Epoetin Alfa) in Maintaining Hemoglobin Levels in Patients With Chemotherapy Related Anemia (NCT00495378) | Ortho Biotech Products, L.P. | 2002-11-01 |
| Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases (NCT00268398) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2002-07-01 |
| Cologne Cohort of Neutropenic Patients (CoCoNut) (NCT01821456) | University Hospital of Cologne | 1995-01-01 |
| Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa (NCT03977818) | Institut Bergonié | 1990-01-01 |
| Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction (NCT00037804) | Pfizer | |